Arena Pharmaceuticals Shares Explode on Positive Ulcerative Colitis Trial Data By Sam | March 19, 2018 Arena Pharmaceuticals released positive top-line results from its Phase II trial of etrasimod in ulcerative colitis. Source: BioSpace Posted in BioPharma